M42 has begun a 10,000-patient pilot in Abu Dhabi using wearable health data to personalise care for people with kidney disease and diabetes, in what the company says is a move towards bringing continuous monitoring into routine clinical care.
Commenting on the opening, Dimitris Moulavasilis, GroupChief Executive Officer of M42, said, “At M42, we are building a global health intelligence platform that brings together clinical expertise, ...
The collaboration marks another milestone in M42's ongoing efforts to strengthen the UAE's position as a global hub for healthcare innovation and AI-enabled healthcare transformation ... Ali Anees, Chief Operating Officer UAE and Bahrain at M42.